Top hospital heart failure performance translates to longer survival
ORLANDO – Get With the Guidelines data show that quality hospital care lengthens lives.
VIDEO: Andexanet alfa effectively reverses factor Xa anticoagulant
ORLANDO – Now that reversal is possible prescriptions for the already-popular direct Factor Xa inhibitor, anticoagulants should spike higher.
Beware of polypharmacy in patients taking warfarin
SAN DIEGO – The incidence of polypharmacy among patients on warfarin therapy appears to peak at age 75.
DOACs may be beneficial in post-op atrial fib after CABG
The use of direct oral anticoagulants were not significantly different from warfarin for safety and efficacy in cases of post-op atrial fib...
VIDEO: Dabigatran effective for myocardial injury after noncardiac surgery
ORLANDO – There’s now treatment for a condition that’s been rarely looked at until now.
Ticagrelor noninferior to clopidogrel in terms of major bleeds in STEMI
New STEMI data answer some but not all questions.
ODYSSEY Outcomes trial redefines secondary cardiovascular prevention
ORLANDO – “I believe this trial is going to change practice.” – Valentin Fuster, MD
Post-ACS death lowered in ODYSSEY Outcomes
ORLANDO – Mortality and major adverse cardiovascular events were cut 15%, but that’s not all.
Mild cognitive impairment rises in heart patients with comorbidities
ANAHEIM, CALIF. – Across the spectrum of cardiovascular disease, the higher the likelihood of mild cognitive impairment, Jocasta Ball, PhD,...
FDA warns against clarithromycin use in patients with heart disease
Clarithromycin may lead to an increased chance of heart problems or death years after use.